These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38893312)

  • 1. Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels.
    Qunies AM; Spitznagel BD; Du Y; Peprah PK; Mohamed YK; Weaver CD; Emmitte KA
    Molecules; 2024 May; 29(11):. PubMed ID: 38893312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685.
    Qunies AM; Spitznagel BD; Du Y; David Weaver C; Emmitte KA
    Bioorg Med Chem; 2023 Nov; 95():117487. PubMed ID: 37812884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
    M Qunies A; A Emmitte K
    Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.
    Qunies AM; Mishra NM; Spitznagel BD; Du Y; Acuña VS; David Weaver C; Emmitte KA
    Bioorg Med Chem Lett; 2022 Nov; 76():129013. PubMed ID: 36184030
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Iraci N; Carotenuto L; Ciaglia T; Belperio G; Di Matteo F; Mosca I; Carleo G; Giovanna Basilicata M; Ambrosino P; Turcio R; Puzo D; Pepe G; Gomez-Monterrey I; Soldovieri MV; Di Sarno V; Campiglia P; Miceli F; Bertamino A; Ostacolo C; Taglialatela M
    J Med Chem; 2024 Jun; 67(11):9124-9149. PubMed ID: 38782404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons.
    Spitznagel BD; Mishra NM; Qunies AM; Prael FJ; Du Y; Kozek KA; Lazarenko RM; Denton JS; Emmitte KA; Weaver CD
    ACS Chem Neurosci; 2020 Nov; 11(21):3658-3671. PubMed ID: 33143429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K
    Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK
    J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.
    Evely KM; Pryce KD; Bhattacharjee A
    Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K
    Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK
    Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
    Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
    Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
    Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
    Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilising Automated Electrophysiological Platforms in Epilepsy Research.
    Milligan CJ; Pachernegg S
    Methods Mol Biol; 2021; 2188():133-155. PubMed ID: 33119850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epilepsy of Infancy With Migrating Focal Seizures: Identification of
    Mao X; Bruneau N; Gao Q; Becq H; Jia Z; Xi H; Shu L; Wang H; Szepetowski P; Aniksztejn L
    Front Cell Neurosci; 2020; 14():1. PubMed ID: 32038177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
    Wu J; Quraishi IH; Zhang Y; Bromwich M; Kaczmarek LK
    Cell Rep; 2024 Mar; 43(3):113904. PubMed ID: 38457342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of
    McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
    Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.
    Rizzo F; Ambrosino P; Guacci A; Chetta M; Marchese G; Rocco T; Soldovieri MV; Manocchio L; Mosca I; Casara G; Vecchi M; Taglialatela M; Coppola G; Weisz A
    Mol Cell Neurosci; 2016 Apr; 72():54-63. PubMed ID: 26784557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotic drug loxapine is an opener of the sodium-activated potassium channel slack (Slo2.2).
    Biton B; Sethuramanujam S; Picchione KE; Bhattacharjee A; Khessibi N; Chesney F; Lanneau C; Curet O; Avenet P
    J Pharmacol Exp Ther; 2012 Mar; 340(3):706-15. PubMed ID: 22171093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of the First Orally Available, Selective K
    Griffin AM; Kahlig KM; Hatch RJ; Hughes ZA; Chapman ML; Antonio B; Marron BE; Wittmann M; Martinez-Botella G
    ACS Med Chem Lett; 2021 Apr; 12(4):593-602. PubMed ID: 33859800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ALS-Associated Mutant SOD1 Rapidly Suppresses KCNT1 (Slack) Na
    Zhang Y; Ni W; Horwich AL; Kaczmarek LK
    J Neurosci; 2017 Feb; 37(8):2258-2265. PubMed ID: 28119399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Coupling of Slack Channels and P2X3 Receptors Contributes to Neuropathic Pain Processing.
    Lu R; Metzner K; Zhou F; Flauaus C; Balzulat A; Engel P; Petersen J; Ehinger R; Bausch A; Ruth P; Lukowski R; Schmidtko A
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.